| 标题 |
内容 |
来源 |
更新时间 |
| MedSci Healthcare |
MedSci Health is the leading integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Medical Affair Service Organization, is purpose-built to accelerate customer performance to address modern market realities. |
前往 |
2026-08-28 22:55 |
| 首席招聘官_中国企业首席招聘官专属读本_一览英才网 |
首席招聘官杂志，中国企业首席招聘官专属读本，引领人才招聘创新思维，提供人才招聘与人才管理的深刻见解，搭建中国企业人力资源管理者（CEO/CHO/CHD/CHM)参与、交流、分享的平台，打造新时代中国企业的首席招聘官！ |
前往 |
2026-03-24 13:40 |
| SYNthesis Med Chem |
|
前往 |
2026-03-29 00:13 |
|
Contract Research Organization | R&D Services | Pharmaron
|
A premier R&D service provider for the life sciences industry, Pharmaron offers diverse R&D service capabilities ranging from medicinal and analytical chemistry, pharmacology, drug safety assessment and radiochemistry, chemical & pharmaceutical development to clinical development. |
前往 |
2026-03-29 00:32 |
| 凯锐斯 |
上海凯锐斯生物科技有限公司 |
前往 |
2026-03-29 00:40 |
| 《2021大健康产业高质量发展大会》_聚智创新，融合发展_与智博会同行_药智网 |
聚智创新，融合发展，与智博会同行！《2021大健康产业高质量发展大会暨第六届中国医药研发·创新峰会》将于2021年9月18-19日在重庆举行，本次会议邀请医药监管领域领导、医药行业顶尖专家、领军人物、企业高管、研发精英等，围绕国家政策及行业趋势，创新药物发展战略与研发策略，医药大数据与人工智能等前沿热门话题进行广泛而深入的探讨。 |
前往 |
2026-04-04 13:41 |
| A Custom Synthesis Company - Capot Chemical |
Capot Chemical is a Custom Synthesis Company. At Capot,We can synthesize and manufacture your complex molecules from 1 gram to 10+tons.CMO,CDMO,CRO,FTE,R&D Company. |
前往 |
2026-04-25 17:49 |
| 小分子CRO_CDMO_CMO_化学原料药_生物制剂_重庆博腾制药科技股份有限公司 |
博腾制药，博腾股份，CRO，CDMO，CMO，原料药，晶型研究，小分子CRO_CDMO_CMO_化学原料药_生物制剂" name="keywords" />
|
前往 |
2026-08-26 15:40 |
|
Contract Research Organization(CRO) | Preclinical CRO | Medicilon Inc |
Medicilon,a contract research organization(CRO), can provide one-stop integrated services including Biology, Chemistry and Preclinical services. Medicilon has been recognized as one of the professional drug discovery preclinical CRO in China. |
前往 |
2026-03-29 00:32 |
| 银星集团 |
银星集团是一家以实业投资、产业地产开发与运营为主营业务的跨行业综合性高科技企业集团。以深圳为总部，业务辐射北京、上海、武汉、惠州、贵州等地，行业涉及人工智能、信息技术、生物制药、产业地产等领域。 |
前往 |
2026-08-28 09:55 |
